Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Aditum Bio
Biotech
VC firm, Chinese biotech launch autoimmune-focused Oblenio Bio
Oblenio was spun out of Leads Biolabs, which can receive up to $35 million in upfront and near-term payments and $579 million in milestone payments.
Darren Incorvaia
Nov 7, 2024 11:35am
Aditum finds twist on old idea, paying $10M for BTK inhibitor
Apr 28, 2023 6:11am
Before exiting J&J, Gorsky lands on Apple board—Chutes & Ladders
Nov 12, 2021 9:30am
Joe Jimenez's Ancora Bio poaches Sage CMO to revive Taisho drug
Nov 8, 2021 10:50am
Aditum launches Ancora with rights to Taisho's depression drug
Jul 1, 2021 11:51am
Novartis alums Jimenez, Fishman unveil their next act
Nov 2, 2020 7:00am